india glp 1 Did you know? is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up in diabetes & obesity care #MarketTalks #EdelweissMutualFund India's GLP-1 Adoption Lags Despite

But used wisely, with resistance training, protein optimisation, and patient selection, they may represent the most significant advance in cardiometabolic medicine since statins

Through this link, GLP-1 drugs can play a role in regulating dopamine pathways that are highly relevant in addictive behaviours

So weight loss, when achieved, often does more than improve the number on the scale

Again, based on their cost and unknown long-term effects, MedBen Rx does not recommend covering obesity drugs at this time but if you are thinking of covering them, we will work with you to examine potential options and implement a strategy that addresses employee needs.

As technologies like AI-powered triage and remote monitoring evolve, the role of telehealth in chronic disease management will only expand

Blood Pressure The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP), a series of trials demonstrated benefits for heart failure (HFpEF) and blood pressure control